Guillain-Barre Syndrome Market Size, Share & Trends Analysis Report By Product | Forecast to 2029
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Will The Guillain-Barre Syndrome Market Valuation Change Between Now And 2029?
In the preceding years, the guillain-barre syndrome market has witnessed robust growth. The size of the market is forecasted to increase from $0.6 billion in 2024 to $0.64 billion in 2025, experiencing a compound annual growth rate (CAGR) of 5.6%. Factors contributing to the growth during the historical period include a surge in the need for GBS treatments, increasing viral infections, more extensive global vaccination drives, enhanced comprehension of autoimmune processes, and growth in knowledge and diagnosis.
The market for Guillain-Barre Syndrome is projected to experience significant expansion in the upcoming years, escalating to a worth of $0.79 billion by 2029, with a compound annual growth rate of 5.5%. This anticipated growth during the projected period can be tied to factors such as the rising incidence of Guillain-Barre Syndrome, the escalating effects of climate change, an upswing in the utilization of immunotherapies and drugs, enhanced diagnostic abilities, and an increase in cases of multifocal motor neuropathy. Leading trends for the forecast period comprise of advanced diagnostic approaches, the evolution of immunoglobulin treatments, advancements in plasmapheresis techniques, the investigation into gene therapy, a heightened emphasis on early intervention, the discovery of innovative prognostic biomarkers, and the increase in clinical trials exploring cutting-edge treatments.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21198&type=smp
What Underlying Factors Are Supporting The Guillain-Barre Syndrome Market Growth?
The rise in immunological diseases is anticipated to spur the expansion of the guillain-barre syndrome market. Overactivity, underactivity, or misdirection of the immune system results in immunological diseases, which further lead to disorders like autoimmune diseases, allergies, and immunodeficiencies. Several factors, such as environmental changes, lifestyle, improved diagnosis, and genetic predisposition are contributing to the rise of these diseases. An autoimmune response triggered by these diseases may result in guillain-barré syndrome, whereby the body’s immune system erroneously attacks the peripheral nerves, causing inflammation and nerve damage. For example, a report released by the Joint United Nations Programme on HIV/AIDS (UNAIDS), a Switzerland-based government organization, in July 2024, revealed that around 39.5 million people across the world were living with HIV by the end of 2022, with 1.3 million new infections and 630,000 AIDS-related deaths reported that year. By 2023, there was an increase in the global count of people living with HIV to about 39.9 million. Thus, the escalating risk of immunological diseases fuels the growth of the guillain-barre syndrome market.
Which Sub-Segments Are Driving Growth Within The Guillain-Barre Syndrome Market?
The guillain-barre syndromemarket covered in this report is segmented –
1) By Type: Acute Inflammatory Demyelinating Polyneuropathy (AIDP); Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP); Miller Fisher Syndrome (MFS); Acute Motor Axonal Neuropathy (AMAN); Other Types
2) By Therapeutics: Intravenous Immunoglobulin (IVIG); Plasma Exchange; Other Therapeutics
3) By Route Of Administration: Parenteral; Oral
4) By End User: Hospitals; Clinics; Diagnostic Centers; Other End Users
Subsegments:
1) By Acute Inflammatory Demyelinating Polyneuropathy (AIDP): Classical AIDP; AIDP with Autonomic Involvement
2) By Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): Progressive CIDP; Relapsing-Remitting CIDP; Multifocal CIDP
3) By Miller Fisher Syndrome (MFS): Classical MFS; MFS With Ataxia; MFS With Ophthalmoplegia
4) By Acute Motor Axonal Neuropathy (AMAN): Classical AMAN; AMAN with Respiratory Involvement
5) By Other Types: Acute Sensory Ganglionopathy; Variants With Cranial Nerve Involvement; Bickerstaff Brainstem Encephalitis
What Key Trends Are Driving Growth In The Guillain-Barre Syndrome Market?
Companies in the Guillain-Barre syndrome market are advancing novel therapies such as monoclonal antibodies to boost treatment effectiveness and fulfill clinical gaps. These lab-designed proteins target specific antigens to adjust immune responses. In October 2023, U.S.-based Annexon Inc. received orphan drug designation from the European Medicines Agency for ANX005, a monoclonal antibody targeting C1q, for Guillain-Barre syndrome. The treatment has shown early signs of improved muscle strength and reduced need for ventilation versus IVIg, indicating promising therapeutic benefits.
Which Companies Hold A Competitive Edge In The 1431 Market?
Major companies operating in the guillain-barre syndrome market are Pfizer Inc., Roche AG, Thermo Fisher Scientific Inc., AstraZeneca PLC, GSK plc, Takeda Pharmaceutical Company Limited, Merck & Co. Inc., Baxter International Inc., Biogen Inc., Horizon Therapeutics, Octapharma AG, Kedrion S.p.A., Annexon Inc., Immunovant Inc., CSL Behring LLC, Hansa Biopharma AB, NeuLine Health Inc., Ridge Diagnostics Inc., Deymed Diagnostic LLC, VYVGART Hytrulo.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/guillain-barre-syndrome-global-market-report
Which Region Dominates The Guillain-Barre Syndrome Market Today?
North America was the largest region in the guillain-barre syndrome market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the guillain-barre syndrome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=21198&type=smp
Browse Through More Reports Similar to the Global Guillain-Barre Syndrome Market 2025, By The Business Research Company
Hepatorenal Syndrome Treatment Global Market Report 2025
Myelodysplastic Syndrome Drugs Global Market Report 2025
Dry Eye Syndrome Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/dry-eye-syndrome-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
